There’s information. And then there’s intelligence.

PharmSource’s accurate, insightful Trend Reports provide context and meaning that’s critical to decision-makers in the bio/pharma contract services arena. Our experts identify trends and forecast changes – delivering the knowledge and understanding necessary to achieve optimal strategic outcomes.

Demand and Supply for Contract Manufacturing of Injectable Drugs Through 2023

This report is the 6th edition of our long-running analysis of the injectables CMO industry. It provides an expert quantitative analysis on the latest trends and plans for outsourcing commercially approved injectable products.

Learn more

CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2018 Edition

This report is the 8th edition of our long running analysis of the CMO Industry, using NDA approvals as the primary indicator of performance. CMO Scorecard is critical for benchmarking the performance of the CMO industry and the relative performance of major CMOs.

Learn more

Cell Therapy Market Opportunity for CMOs – 2018 Edition

This expert trend report is an indispensable resource for understanding the technical developments in the cell therapy sector and the scale of the clinical and commercial opportunities and risks for CMOs.

Learn more

PharmSource – Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars – 2018 Edition

Biosimilars are drugs that are highly similar but not identical to branded “innovator” biologics: large molecule, immunogenic drugs produced from living cells. “Innovator” biologics are the first to be approved, and when their patent protection expires, biosimilars may be approved, in a similar way to small molecule branded drugs and their generics…….

Learn more

M&A in the Contract Manufacturing Industry: Implications and Outlook – 2018 Edition

This repoprt analyzes merger and acquisition (M&A) activity in the pharmaceutical contract manufacturing industry during the period 2015–2017 and assesses the implications for acquirers and sellers of such services. The services considered in this report are contract manufacturing of active pharmaceutical ingredients (APIs) and finished dose products, associated analytical services, and packaging. Contract research providers were excluded….

Learn more

Dose CMOs by the Numbers: Composition, Size, Market Share and Outlook

This proprietary report is based on PharmSource’s expert quantitative analysis of the contract dose manufacturing market. It will help you understand the events behind both organic and inorganic revenue changes.

PharmSource’s experts explain the relative market shares of solid, semi-solid/liquid/injectable and…

Learn more